Gallstone gene identified
This article was originally published in Clinica
A team of European scientists has identified a gallstone gene variant that could increase the risk of developing gallstones by around 2-3 times. The researchers believe that this is the first identified gene that can indicate the risk of gallstones across the general population. The team, based at the University of Bonn in Germany, and the University Clinic of Cluj-Napoca in Romania, said that the findings could lead to more successful prevention and therapy of the condition.
You may also be interested in...
A recent segment of CBS News “60 Minutes” discussing potential health benefits from probiotics was highly criticized by groups including the Consumer Healthcare Products Association, the Council for Responsible Nutrition, the Natural Products Association and the International Probiotics Association.
After a 12-month period that has seen Stada make significant investments in generics, biosimilars and consumer healthcare, CEO Peter Goldschmidt tells Generics Bulletin that the firm does not intend to stop there, as it pursues both organic and inorganic growth opportunities.
Samsung Bioepis is the latest company to stare down a lawsuit from Genentech over Avastin patents in the US. The Korean firm is aiming to be amongst the early biosimilar movers, after the market formed a year ago.